Retrieve available abstracts of 55 articles: HTML format
Single Articles
July 2025
WOO S, Becker AS, Leithner D, Mayerhoefer ME, et al Discordance between prostate MRI and PSMA-PET/CT: the next big challenge for
primary prostate tumor assessment?
Eur Radiol. 2025;35:4043-4054. PubMedAbstract available
June 2025
FRANSEN SJ, Bosma JS, van Lohuizen Q, Roest C, et al Simulating workload reduction with an AI-based prostate cancer detection pathway
using a prediction uncertainty metric.
Eur Radiol. 2025 Jun 7. doi: 10.1007/s00330-025-11727. PubMedAbstract available
LEE KL, Caglic I, Liao PH, Kessler DA, et al PI-QUAL version 2 image quality categorisation and inter-reader agreement
compared to version 1.
Eur Radiol. 2025;35:3096-3104. PubMedAbstract available
April 2025
CARLETTI F, Maggi M, Fazekas T, Rajwa P, et al Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate
cancer histology: a systematic review and meta-analysis.
Eur Radiol. 2025 Apr 30. doi: 10.1007/s00330-025-11603. PubMedAbstract available
AGROTIS G, Pooch EP, Marsitopoulos K, Vlychou M, et al Detection rates for prostate cancer using PI-RADS 2.1 upgrading rules in
transition zone lesions align with risk assessment categories: a systematic
review and meta-analysis.
Eur Radiol. 2025 Apr 27. doi: 10.1007/s00330-025-11618. PubMedAbstract available
AZMA YN, Boci N, Abramowicz K, Russo L, et al Influence of imaging method on fat fraction estimation for assessing bone marrow
in metastatic prostate cancer.
Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11564. PubMedAbstract available
NAVES AA, Gouvea GL, Machado CVB, Colli LM, et al MRI-detected extranodal extension as a marker of prostate cancer aggressiveness.
Eur Radiol. 2025 Apr 5. doi: 10.1007/s00330-025-11532. PubMedAbstract available
MAFFEI D, Moore CM Personalized risk-adapted models in prostate cancer during active surveillance
using MRI-a narrative review.
Eur Radiol. 2025 Apr 4. doi: 10.1007/s00330-025-11518. PubMedAbstract available
CAMPBELL RA, Wood A, Schwen Z, Ward R, et al MRI and active surveillance: thoughts from across the pond.
Eur Radiol. 2025;35:2157-2169. PubMedAbstract available
March 2025
EVANGELISTA L, Vallone C, Guglielmo P Optimizing prostate cancer diagnosis: combining imaging modalities for tailored
treatment.
Eur Radiol. 2025 Mar 25. doi: 10.1007/s00330-025-11551. PubMed
WOO S, Becker AS, Leithner D, Charbel C, et al PSMA-avid rib lesions in prostate cancer patients: differentiating false
positives from metastatic disease.
Eur Radiol. 2025 Mar 20. doi: 10.1007/s00330-025-11514. PubMedAbstract available
PADHANI AR, Papanikolaou N AI and human interactions in prostate cancer diagnosis using MRI.
Eur Radiol. 2025 Mar 7. doi: 10.1007/s00330-025-11498. PubMedAbstract available
February 2025
GIGANTI F, Moreira da Silva N, Yeung M, Davies L, et al AI-powered prostate cancer detection: a multi-centre, multi-scanner validation
study.
Eur Radiol. 2025 Feb 28. doi: 10.1007/s00330-024-11323. PubMedAbstract available
HAIDER MA PI-CAI: a landmark AI study for prostate cancer detection on MRI.
Eur Radiol. 2025 Feb 17. doi: 10.1007/s00330-025-11454. PubMed
January 2025
PANEBIANCO V, Catalano C, Sanguedolce F, De Santis M, et al ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view.
Eur Radiol. 2025 Jan 31. doi: 10.1007/s00330-025-11354. PubMed
KLEIBURG F, de Geus-Oei LF, Spijkerman R, Noortman WA, et al Baseline PSMA PET/CT parameters predict overall survival and treatment response
in metastatic castration-resistant prostate cancer patients.
Eur Radiol. 2025 Jan 22. doi: 10.1007/s00330-025-11360. PubMedAbstract available
December 2024
CAVALLO AU, Stanzione A, Ponsiglione A, Trotta R, et al Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing
group initiative.
Eur Radiol. 2024 Dec 30. doi: 10.1007/s00330-024-11299. PubMedAbstract available
DEBS N, Routier A, Bone A, Rohe MM, et al Evaluation of a deep learning prostate cancer detection system on biparametric
MRI against radiological reading.
Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11287. PubMedAbstract available
BAUCKNEHT M, Laudicella R, Lanfranchi F, Ciccarese C, et al PSMA PET/CT in staging recurrent prostate cancer: a viewfinder, not a compass.
Eur Radiol. 2024 Dec 18. doi: 10.1007/s00330-024-11297. PubMed
BAUCKNEHT M, Laudicella R, Lanfranchi F, Burger IA, et al Unspecific bone uptakes in PSMA PET for prostate cancer: why do they matter?
Eur Radiol. 2024 Dec 4. doi: 10.1007/s00330-024-11252. PubMed
DIAS AB, Woo S, Leni R, Rajwa P, et al Is MRI ready to replace biopsy during active surveillance?
Eur Radiol. 2024;34:7716-7727. PubMedAbstract available
BOZGO V, Roest C, van Oort I, Yakar D, et al Prostate MRI and artificial intelligence during active surveillance: should we
jump on the bandwagon?
Eur Radiol. 2024;34:7698-7704. PubMedAbstract available
November 2024
RATA M, Orton MR, Tunariu N, Curcean A, et al Repeatability of quantitative MR fingerprinting for T(1) and T(2) measurements of
metastatic bone in prostate cancer patients.
Eur Radiol. 2024 Nov 6. doi: 10.1007/s00330-024-11162. PubMedAbstract available
DE ROOIJ M, Allen C, Twilt JJ, Thijssen LCP, et al PI-QUAL version 2: an update of a standardised scoring system for the assessment
of image quality of prostate MRI.
Eur Radiol. 2024;34:7068-7079. PubMedAbstract available
PONSIGLIONE A, Brembilla G, Cuocolo R, Gutierrez P, et al ESR Essentials: using the right scoring system in prostate MRI-practice
recommendations by ESUR.
Eur Radiol. 2024;34:7481-7491. PubMedAbstract available
VAN LOHUIZEN Q, Roest C, Simonis FFJ, Fransen SJ, et al Assessing deep learning reconstruction for faster prostate MRI: visual vs.
diagnostic performance metrics.
Eur Radiol. 2024;34:7364-7372. PubMedAbstract available
October 2024
HAMM CA, Baumgartner GL, Padhani AR, Frobose KP, et al Reduction of false positives using zone-specific prostate-specific antigen
density for prostate MRI-based biopsy decision strategies.
Eur Radiol. 2024;34:6229-6240. PubMedAbstract available
MARVASO G, Isaksson LJ, Zaffaroni M, Vincini MG, et al Can we predict pathology without surgery? Weighing the added value of
multiparametric MRI and whole prostate radiomics in integrative machine learning
models.
Eur Radiol. 2024;34:6241-6253. PubMedAbstract available
September 2024
BOSCHHEIDGEN M, Schimmoller L, Radtke JP, Kastl R, et al MRI characteristics predict risk of pathological upgrade in patients with ISUP
grade group 1 prostate cancer.
Eur Radiol. 2024 Sep 13. doi: 10.1007/s00330-024-11062. PubMedAbstract available
August 2024
FRANSEN SJ, Kwee TC, Rouw D, Roest C, et al Patient perspectives on the use of artificial intelligence in prostate cancer
diagnosis on MRI.
Eur Radiol. 2024 Aug 14. doi: 10.1007/s00330-024-11012. PubMedAbstract available
ISRAEL B From data to decisions: deep learning is shaping prostate cancer diagnostics.
Eur Radiol. 2024 Aug 2. doi: 10.1007/s00330-024-10997. PubMed
July 2024
AGROTIS G, Pooch E, Abdelatty M, Benson S, et al Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer
assessment: A systematic review and meta-analysis.
Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10890. PubMedAbstract available
SCHRADER A, Netzer N, Hielscher T, Gortz M, et al Prostate cancer risk assessment and avoidance of prostate biopsies using fully
automatic deep learning in prostate MRI: comparison to PI-RADS and integration
with clinical data in nomograms.
Eur Radiol. 2024 Jul 2. doi: 10.1007/s00330-024-10818. PubMedAbstract available
STANZIONE A, Lee KL, Sanmugalingam N, Rajendran I, et al Expect the unexpected: investigating discordant prostate MRI and biopsy results.
Eur Radiol. 2024;34:4810-4820. PubMedAbstract available
LANGKILDE F, Masaba P, Edenbrandt L, Gren M, et al Manual prostate MRI segmentation by readers with different experience: a study of
the learning progress.
Eur Radiol. 2024;34:4801-4809. PubMedAbstract available
June 2024
PADHANI AR, Tunariu N, Perez-Lopez R, Tombal B, et al Evaluating prostate cancer bone metastases response with whole-body MRI: What we
know and still need to know.
Eur Radiol. 2024 Jun 20. doi: 10.1007/s00330-024-10864. PubMed
NAKAI H, Suman G, Adamo DA, Navin PJ, et al Natural language processing pipeline to extract prostate cancer-related
information from clinical notes.
Eur Radiol. 2024 Jun 6. doi: 10.1007/s00330-024-10812. PubMedAbstract available
PONSIGLIONE A, Gambardella M, Stanzione A, Green R, et al Radiomics for the identification of extraprostatic extension with prostate MRI: a
systematic review and meta-analysis.
Eur Radiol. 2024;34:3981-3991. PubMedAbstract available
May 2024
OERTHER B, Engel H, Nedelcu A, Strecker R, et al Performance of an ultra-fast deep-learning accelerated MRI screening protocol for
prostate cancer compared to a standard multiparametric protocol.
Eur Radiol. 2024 May 23. doi: 10.1007/s00330-024-10776. PubMedAbstract available
BREMBILLA G, Giganti F Improving image quality in prostate MRI: the time is now.
Eur Radiol. 2024;34:3385-3386. PubMed
NAKAI H, Takahashi H, Adamo DA, LeGout JD, et al Decreased prostate MRI cancer detection rate due to moderate to severe
susceptibility artifacts from hip prosthesis.
Eur Radiol. 2024;34:3387-3399. PubMedAbstract available
April 2024
MUGLIA VF Refining clinical decision strategies and prostate cancer detection through fine
adjustments in the combination of PSA-derived parameters and MRI.
Eur Radiol. 2024 Apr 29. doi: 10.1007/s00330-024-10734. PubMed
CAGLIC I, Sushentsev N, Syer T, Lee KL, et al Biparametric MRI in prostate cancer during active surveillance: is it safe?
Eur Radiol. 2024 Apr 24. doi: 10.1007/s00330-024-10770. PubMedAbstract available
BOELLAARD TN, van Dijk-de Haan MC, Heijmink SWTPJ, Tillier CN, et al Membranous urethral length measurement on preoperative MRI to predict
incontinence after radical prostatectomy: a literature review towards a proposal
for measurement standardization.
Eur Radiol. 2024;34:2621-2640. PubMedAbstract available
March 2024
GIROMETTI R, Giganti F Active surveillance of prostate cancer: MRI and beyond.
Eur Radiol. 2024 Mar 28. doi: 10.1007/s00330-024-10717. PubMed
February 2024
PADHANI AR, Godtman RA, Schoots IG Key learning on the promise and limitations of MRI in prostate cancer screening.
Eur Radiol. 2024 Feb 5. doi: 10.1007/s00330-024-10626. PubMedAbstract available
January 2024
MAZZETTI S, Defeudis A, Nicoletti G, Chiorino G, et al Development and validation of a clinical decision support system based on PSA,
microRNAs, and MRI for the detection of prostate cancer.
Eur Radiol. 2024 Jan 4. doi: 10.1007/s00330-023-10542. PubMedAbstract available
PANEBIANCO V Prostate cancer imaging for primary detection: PSMA-PET/CT vs MRI. All that
glitters is not gold.
Eur Radiol. 2024 Jan 2. doi: 10.1007/s00330-023-10547. PubMed
December 2023
EVANGELISTA L, Filippi L Structured reporting in prostate cancer: the revolution of quality in nuclear
medicine scan interpretation.
Eur Radiol. 2023 Dec 20. doi: 10.1007/s00330-023-10507. PubMed
NOTO B, Eveslage M, Auf der Springe K, Exler A, et al Robustness of apparent diffusion coefficient-based lymph node classification for
diagnosis of prostate cancer metastasis.
Eur Radiol. 2023 Dec 15. doi: 10.1007/s00330-023-10406. PubMedAbstract available
JANNUSCH K, Bruckmann NM, Morawitz J, Boschheidgen M, et al Recurrent prostate cancer: combined role for MRI and PSMA-PET in (68)Ga-PSMA-11
PET/MRI.
Eur Radiol. 2023 Dec 1. doi: 10.1007/s00330-023-10442. PubMedAbstract available
ROUVIERE O Contrast-medium administration for prostate MRI can be abandoned: no(t so
simple)!
Eur Radiol. 2023;33:8415-8416. PubMed
ASBACH P Contrast-medium administration for prostate MRI: yes! Contrast-medium
administration can be abandoned.
Eur Radiol. 2023;33:8413-8414. PubMed
November 2023
MA J, Yang Q, Ye X, Xu W, et al Head-to-head comparison of prostate-specific membrane antigen PET and
multiparametric MRI in the diagnosis of pretreatment patients with prostate
cancer: a meta-analysis.
Eur Radiol. 2023 Nov 20. doi: 10.1007/s00330-023-10436. PubMedAbstract available
NETZER N, Eith C, Bethge O, Hielscher T, et al Application of a validated prostate MRI deep learning system to independent
same-vendor multi-institutional data: demonstration of transferability.
Eur Radiol. 2023;33:7463-7476. PubMedAbstract available